Peter Nørregaard Hansen

Peter Nørregaard Hansen is a researcher affiliated with the Department of Clinical Research at the University of Southern Denmark, and works within the Research Unit of Neurology in Odense. He is also associated with the Karolinska Institute (KI) and Odense University Hospital (OUH). His work focuses on neurological disorders and immunotherapeutic interventions.

• University of Southern Denmark - Department of Clinical Research
• Karolinska Institute (KI)
• Odense University Hospital (OUH)
• Research Unit of Neurology (Odense)

Dr. Hansen’s research interests span multiple areas of neuroscience and clinical neurology, particularly in chronic inflammatory demyelinating polyneuropathy (CIDP) and Parkinson’s disease. He explores the application of immunotherapy, including intravenous immunoglobulin (IVIG), and investigates neuropathic pain mechanisms and pharmacological treatments like lacosamide. His work also delves into the genetic underpinnings of neurological conditions using iPSC-derived neural cells.

His most recent publications highlight advancements in motor unit number estimation (MScanFit) for CIDP assessment, the efficacy of lacosamide for neuropathic pain, and RhoA signaling perturbations in PARK2-related Parkinson’s disease. These works reflect a strong emphasis on clinical neurophysiology, immunomodulation, and translational research bridging bench and bedside.

Dr. Hansen’s contributions are primarily within the neurology and neuroscience domains, with applications to clinical treatment, pain management, and neuroimmunology. He is actively involved in collaborative research, as evidenced by his international network and co-authorship on multidisciplinary studies.